Doxiciclina como coadyuvante en el tratamiento no quirúrgico de la enfermedad Periodontal.

Abstract

Periodontal disease, considered among the different infections that manifest in the oral cavity, is considered a public health problem, which is why antibiotic prescription is required; Still 10% of antibiotics are used to treat this type of infection. The choice of specific antibiotics for this type of alterations is based on the presence of the oral flora; Therefore, there is a high rate of resistance to drugs, especially those that are antimicrobial, and this is worldwide. The objective: Analyze the use of Doxycycline as an adjuvant in the non-surgical treatment of periodontal disease. Methodology as it is a review of the literature, a database was created using Boolean search engines, with application of the inclusion and exclusion criteria in a systematic manner with publications from the last 9 years. Results were 20 articles, published between 2014 and 2022, forming the basis of the study; seven articles correspond to Systematic Review; three are Clinical studies; two correspond between a Cross-sectional Retrospective Descriptive Study and a Clinical Practice Guideline, in which the Management of Doxycycline is described as an adjuvant in the non-surgical treatment of periodontal disease. Conclusion Subantimicrobial dose of doxycycline (SDD - 20 mg doxycycline twice daily) is indicated as an adjuvant treatment for periodontitis.